Formulation strategies for nose-to-brain delivery of therapeutic molecules
Authors:
- Vikas PandeyVPVikas Pandey
- Anuradha GadevalAGAnuradha Gadeval
- Saket AsatiSASaket Asati
- Priyanka JainPJPriyanka Jain
- Navneet JainNJNavneet Jain
- Ram Kumar RoyRRRam Kumar Roy
- Muktika TekadeMTMuktika Tekade
- Vandana SoniVSVandana Soni
- Rakesh K. TekadeRTRakesh K. Tekade
- 1 January 2020
- book chapter
- Published by Elsevier
- p. 291-332
Abstract
No abstract availableKeywords
This publication has 165 references indexed in Scilit:
- Nasal drug delivery devices: characteristics and performance in a clinical perspective—a reviewDrug Delivery and Translational Research, 2012
- Effects of intranasal oxytocin and vasopressin on cooperative behavior and associated brain activity in menPsychoneuroendocrinology, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- The Science of Stroke: Mechanisms in Search of TreatmentsNeuron, 2010
- Intranasal administration of IGF-1 attenuates hypoxic-ischemic brain injury in neonatal ratsExperimental Neurology, 2009
- Rapid transport of large polymeric nanoparticles in fresh undiluted human mucusProceedings of the National Academy of Sciences, 2007
- The “Perivascular Pump” Driven by Arterial Pulsation Is a Powerful Mechanism for the Distribution of Therapeutic Molecules within the BrainMolecular Therapy, 2006
- Mechanisms to explain the reverse perivascular transport of solutes out of the brainJournal of Theoretical Biology, 2006
- Oxytocin increases trust in humansNature, 2005
- Neuroprotective effects of estradiol-17β: implications for psychiatric disordersArchives of Women's Mental Health, 2002